These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15254744)

  • 1. Usefulness of immunomodulators for maturation of dendritic cells.
    Ogihara T; Iinuma H; Okinaga K
    Int J Oncol; 2004 Aug; 25(2):453-9. PubMed ID: 15254744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
    Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
    Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dendritic cells matured early with OK-432 (Picibanil), prostaglandin E2, and interferon-alpha as a vaccine for a hormone refractory prostate cancer cell line.
    Yoo C; Do HA; Jeong IG; Park H; Hwang JJ; Hong JH; Cho JS; Choo MS; Ahn H; Kim CS
    J Korean Med Sci; 2010 Sep; 25(9):1284-90. PubMed ID: 20808670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells.
    Itoh T; Ueda Y; Okugawa K; Fujiwara H; Fuji N; Yamashita T; Fujiki H; Harada S; Yoshimura T; Yamagishi H
    Cancer Immunol Immunother; 2003 Apr; 52(4):207-14. PubMed ID: 12669245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells.
    Koido S; Hara E; Homma S; Torii A; Mitsunaga M; Yanagisawa S; Toyama Y; Kawahara H; Watanabe M; Yoshida S; Kobayashi S; Yanaga K; Fujise K; Tajiri H
    J Immunol; 2007 Jan; 178(1):613-22. PubMed ID: 17182602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran).
    Ghoneum M; Agrawal S
    Int J Immunopathol Pharmacol; 2011; 24(4):941-8. PubMed ID: 22230400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.
    Kuroki H; Morisaki T; Matsumoto K; Onishi H; Baba E; Tanaka M; Katano M
    Cancer Immunol Immunother; 2003 Sep; 52(9):561-8. PubMed ID: 14627128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
    Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
    Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
    Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
    Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2.
    Karlsen M; Hovden AO; Vogelsang P; Tysnes BB; Appel S
    Scand J Immunol; 2011 Aug; 74(2):135-43. PubMed ID: 21449940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
    Zhu M; Xu W; Su H; Huang Q; Wang B
    Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40).
    Toyokawa H; Inaba M; Takai S; Satoi S; Beuth J; Ko HL; Matsui Y; Kwon AH; Kamiyama Y; Ikehara S
    Anticancer Res; 2002; 22(4):2137-45. PubMed ID: 12174895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
    Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
    Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers.
    Shu YQ; Gu Y
    Biomed Pharmacother; 2006 May; 60(4):156-60. PubMed ID: 16647239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2).
    Sato M; Takayama T; Tanaka H; Konishi J; Suzuki T; Kaiga T; Tahara H
    Cancer Sci; 2003 Dec; 94(12):1091-8. PubMed ID: 14662025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation and cytokine production potential of dendritic cells isolated from rheumatoid arthritis patients peripheral blood and induced in vitro.
    Sennikov SV; Falaleeva SA; Shkaruba NS; Chumasova OA; Obleukhova IA; Sizikov AE; Kurilin VV
    Hum Immunol; 2016 Oct; 77(10):930-936. PubMed ID: 27421624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E
    Yi DH; Stetter N; Jakobsen K; Jonsson R; Appel S
    Cancer Immunol Immunother; 2018 Oct; 67(10):1611-1620. PubMed ID: 30069688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.